The role of extracellular DNA (exDNA) in cellular processes

References

• Mandel P, Métais P. Les acides nucléiques du plasma sanguin chez l’homme [The nucleic acids of blood plasma in humans]. C R Seances Soc Biol Fil. 1948;142(3–4):241–243.
   PubMedGoogle Scholar
• Aarthy R, Mani S, Velusami S, Sundarsingh S, Rajkumar T. 2015. Role of circulating cell-free DNA in cancers. Mol Diagn Ther. 19(6):339–350. 10.1007/s40291-015-0167-y.
   PubMed Web of Science ®Google Scholar
• Gahan PB, Anker P, Stroun SM. 2008. Metabolic DNA as the origin of spontaneously released DNA?. Ann NY Acad Sci. 1137(1):7–17. 10.1196/annals.1448.046.
   PubMedGoogle Scholar
• Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M. 2016. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 35(3):347–376. 10.1007/s10555-016-9629-x.
   PubMed Web of Science ®Google Scholar
• Zukowski A, Rao S, Ramachandran S. 2020. Phenotypes from cell-free DNA. Phenotypes from cell-free DNA. Open Biol. 10(9):200119. 10.1098/rsob.200119.
   PubMed Web of Science ®Google Scholar
• Rykova E, Morozkin E, Ponomaryova A, Loseva E, Zaporozhchenko I, Cherdyntseva N, Vlassov V, Laktionov P. 2012. Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content. Expert Opin Biol Ther. 12(Suppl sup1):S141–S153. 10.1517/14712598.2012.673577.
   PubMedGoogle Scholar
• Marzban C, Viswanathan R, Yurtsever U. 2014. Earth before life. Biol Direct. 9(11):1–11. 10.1186/1745-6150-9-1.
   PubMedGoogle Scholar
• Zhang W, Xia W, Lv Z, Ni C, Xin Y, Yang L. 2017. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes?. Cell Physiol Biochem. 41(2):755–768. 10.1159/000458736.
   PubMed Web of Science ®Google Scholar
• Lichtenstein A, Melkonyan H, Tomei LD, Umansky SR. Circulating nucleic acids and apoptosis. Ann NY Acad Sci. 2006;945(1):239–249. doi:10.1111/j.1749-6632.2001.tb03892.x. tb03892.x.
   Google Scholar
• Stroun M, Lyautey J, Olson-Sand A, Anker P. 2001. About the possible origin and mechanism of circulating DNA. Apoptosis and active DNA release. Clin Chim Acta. 313(1–2):139–142. 10.1016/s0009-8981(01)00665-9.
   PubMed Web of Science ®Google Scholar
• Ulivi P, Silvestrini R. 2013. Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer. Cell Oncol. 36(6):439–448. 10.1007/s13402-013-0155-3.
   Web of Science ®Google Scholar
• Bryzgunova OE, Laktionov PP. 2014. Generation of blood circulating DNAs: sources, features of structure and circulation. Biochemistry (Moscow) Supplement Series B: Biomed Chem. 8(3):203–219. 10.1134/S1990750814030020.
   Google Scholar
• Aucamp J, Bronkhorst AJ, Badenhorst CPS, Pretorius PJ. 2018. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev Camb Philos Soc. 93(3):1649, 168. 10.1111/brv.12413.
   Web of Science ®Google Scholar
• Bronkhorst AJ, Wentzel JF, Aucamp J, Van Dyk E, Du Plessis L, Pretorius PJ. 2016. Characterization of the cell-free DNA released by cultured cancer cells. Biochim Biophys Acta. 1863(1):157–165. 10.1016/j.bbamcr.2015.10.022.
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;614:1659–1665. PMID: 11245480.
   Google Scholar
• Pös O, Biró O, Szemes T, Nagy B. 2018. Circulating cell-free nucleic acids: characteristics and applications. Eur J Hum Genet. 26(7):937–945. 10.1038/s41431-018-0132-4.
   PubMed Web of Science ®Google Scholar
• Lam WKJ, Gai W, Sun K, Wong RSM, Chan RWY, Jiang P, Chan NPH, Hui WWI, Chan AWH, ChCh S, et al. 2017. DNA of erythroid origin is present in human plasma and informs the types of anemia. Clin Chem. 63:1614–1623. 10.1373/clinchem.2017.272401.
   PubMed Web of Science ®Google Scholar
• Sato Y, Matoba R, Kato K. 2019. Recent advances in liquid biopsy in precision oncology research. Biol Pharm Bull. 42(3):337–342. 10.1248/bpb.b18-00804.
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al. 2008. Circulating mutant DNA to assess tumor dynamics. Nat Med. 14(9):985–990. DOI:10.1038/nm.1789
   PubMed Web of Science ®Google Scholar
• Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther. 2019;20(8):1057–1067. doi:10.1080/15384047.2019. 1598759.
   PubMed Web of Science ®Google Scholar
• Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS. 2006. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 24(26):4270–4276. 10.1200/JCO.2006.05.9493.
   PubMed Web of Science ®Google Scholar
• Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, et al. 2008. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the Perugia multidisciplinary team for thoracic oncology. J Thorac Oncol. 3(4):365–373. DOI:10.1097/JTO.0b013e318168c7d0
   PubMed Web of Science ®Google Scholar
• Li L, Hann HW, Wan S, Hann RS, Wang C, Lai Y, Ye X, Evans A, Myers RE, Ye Z, et al. 2016. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection. Sci Rep. 6(1):23992. DOI:10.1038/srep23992
   PubMedGoogle Scholar
• Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, Del Rio M, Molina F. 2010. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 38(18):6159–6175. 10.1093/nar/gkq421.
   PubMed Web of Science ®Google Scholar
• Duforestel M, Briand J, Bougras-Cartron G, Heymann D, Frenel J-S, Vallette FM, Cartron P-F. 2020. Cell-free circulating epimarks in cancer monitoring. Epigenomics. 12(2):145–155. 10.2217/epi-2019-0170.
   PubMed Web of Science ®Google Scholar
• Fernández-Lázaro D, García Hernández JL, García AC, Córdova Martínez A, Mielgo-Ayuso J, Cruz-Hernández JJ. 2020. Liquid Biopsy as Novel Tool in Precision Medicine: origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers. Diagnostics (Basel). 10(4):215. 10.3390/diagnostics10040215.
   PubMedGoogle Scholar
• Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. 2020. Molecular profiling for precision cancer therapies. Genome Med. 12(1):8. 10.1186/s13073-019-0703-1.
   PubMed Web of Science ®Google Scholar
• Diaz LA, Bardelli BA. 2014. Liquid Biopsies: genotyping Circulating Tumor DNA. J Clin Oncol. 32(6):579–586. 10.1200/JCO.2012.45.2011.
   PubMed Web of Science ®Google Scholar
• Jensen SØ, Øgaard N, Ørntoft MBW, Rasmussen MH, Bramsen JB, Kristensen H, Mouritzen P, Madsen MR, Madsen AH, Sunesen KG, et al. 2019. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study. Clin Epigenetics. 11(1):158. DOI:10.1186/s13148-019-0757-3
   PubMed Web of Science ®Google Scholar
• Warton K, Mahon KL, Samimi G. 2016. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer. 23(3):R157–R171. 10.1530/ERC-15-0369.
   PubMed Web of Science ®Google Scholar
• Campos-Carrillo A, Weitzel JN, Sahoo P, Rockne R, Mokhnatkin JV, Murtaza M, Gray SW, Goetz L, Goel A, Schork N, et al. Circulating tumor DNA as an early cancer detection tool. Pharmacol Ther. 2020; 207(107458). doi:10.1016/j.pharmthera.2019.107458. pharmthera. 2019.107458.
   PubMedGoogle Scholar
• Chen Q, Zhang Z-H, Wang S, Lang J-H. 2019. <p>Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer. Onco Targets Ther. 12:11517–11530. 10.2147/OTT.S227156.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen P, Xie H, Cao P. 2020. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: a systematic review and meta-analysis. Cancer Med. 9(4):1349–1364. 10.1002/cam4.2799.
   PubMed Web of Science ®Google Scholar
• Reece M, Saluja H, Hollington P, Karapetis CS, Vatandoust S, Young GP, Symonds EL. 2019. The use of circulating tumor DNA to monitor and predict response to treatment in colorectal cancer. Front Genet. 10(1118):1–25. 10.3389/fgene.2019.01118.
   PubMedGoogle Scholar
• Bell E. 1969. I-DNA: its packaging into I-somes and its relation to protein synthesis during differentiation. Nature. 224(5217):326–328. 10.1038/224326a0.
   PubMed Web of Science ®Google Scholar
• Aucamp J, Bronkhorst AJ, Badenhorst CP, Pretorius PJ. 2016. A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles. Cell Mol Life Sci. 73(23):4355–4381. 10.1007/s00018-016-2370-3.
   PubMed Web of Science ®Google Scholar
• Bell BE. 1971. Informational DNA Synthesis Distinguished from That of Nuclear DNA by Inhibitors of DNA Synthesis. Science. 174(4009):603–606. 10.1126/science.174.4009.603.
   PubMed Web of Science ®Google Scholar
• Cai J, Wu G, Jose PA, Zeng C. 2016. Functional transferred DNA within extracellular vesicles. Exp Cell Res. 349(1):179–183. 10.1016/j.yexcr.2016.10.012.
   PubMed Web of Science ®Google Scholar
• Gahan PB, Stroun M. 2010. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct. 28(7):529–538. 10.1002/cbf.1690.
   PubMed Web of Science ®Google Scholar
• Wang W, Kong P, Ma G, Li L, Zhu J, Xia T, Xie H, Zhou W, Wang S. 2017. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget. 8(26):43180–43191. 10.18632/oncotarget.17858.
   PubMedGoogle Scholar
• Nagler M, Insam H, Pietramellara G, Ascher-Jenull A-J-J. 2018. Extracellular DNA in natural environments: features, relevance and applications. Appl Microbiol Biotechnol. 102(15):6343–6356. 10.1007/s00253-018-9120-4.
   PubMed Web of Science ®Google Scholar
• Otandault A, Anker P, Al Amir DZ, Guillaumon V, Meddeb R, Pastor B, Pisareva E, Sanchez C, Tanos R, Tousch G, et al. 2019. Recent advances in circulating nucleic acids in oncology. Ann Oncol. 30(3):374–384. DOI:10.1093/annonc/mdz031
   PubMed Web of Science ®Google Scholar
• Vanpouille-Box C, Demaria S, Formenti SC, Galluzzi GL. 2018. Cytosolic DNA Sensing in Organismal Tumor Control. Cancer Cell. 34(3):361–378. 10.1016/j.ccell.2018.05.013.
   PubMed Web of Science ®Google Scholar
• Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, Rubertsson S, Nellgård B, Blennow K, Zetterberg H, et al. 2016. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci USA. 113(13):E1826–E1834. DOI:10.1073/pnas.1519286113
   PubMed Web of Science ®Google Scholar
• Skvortsova TE, Rykova EY, Tamkovich SN, Bryzgunova OE, Starikov AV, Kuznetsova NP, Vlassov VV, Laktionov PP. 2006. Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer. 94(10):1492–1495. 10.1038/sj.bjc.6603117.
   PubMed Web of Science ®Google Scholar
• Veĭko NN, Bulycheva NV, Roginko OA, Veĭko RV, Ershova ES, Kozdoba OA, Kuz’min VA, Vinogradov AM, Iudin AA, Speranskiĭ AI. 2008. [Ribosomal repeat in the cell free DNA as a marker for cell death]. Biomed Khim. 54(1):78–93. 10.1134/S1990750808020121.
   PubMedGoogle Scholar
• Chen Z, Fadiel A, Naftolin F, Eichenbaum KD, Xia XY. 2005. Circulation DNA: biological implications for cancer metastasis and immunology. Med Hypotheses. 65(5):956–961. 10.1016/j.mehy.2005.04.042.
   PubMed Web of Science ®Google Scholar
• Kozhina EA, Ershova ES, Okorokova NA, Veiko VP, Malinovskaya EM, Sergeeva VA, Konkova MS, Kutsev SI, Veiko NN, Kostyuk SV. 2019. Extracellular DNA Containing (dG)n Motifs Penetrates into MCF7 Breast Cancer Cells, Induces the Adaptive Response, and Can Be Expressed. Oxid Med Cell Longev. 2019:7853492. 10.1155/2019/7853492.
   PubMed Web of Science ®Google Scholar
• Unterholzner L. 2013. The interferon response to intracellular DNA: why so many receptors?. Immunobiology. 218(11):1312–1321. 10.1016/j.imbio.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637–650. doi:10.1016/j.immuni.2011.05.006. 05.006.
   PubMed Web of Science ®Google Scholar
• Harberts E, Gaspari AA. 2013. TLR signaling and DNA repair: are they associated?. J Invest Dermatol. 133(2):296–302. 10.1038/jid.2012.288.
   PubMed Web of Science ®Google Scholar
• Kato H, Takahasi K, Fujita T. 2011. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev. 243(1):91–98. 10.1111/j.1600-065X.2011.01052.x.
   PubMedGoogle Scholar
• Keating SE, Baran M, Bowie AG. 2011. Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol. 32(12):574–581. 10.1016/j.it.2011.08.004.
   PubMed Web of Science ®Google Scholar
• Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 339(6121):786–791. 10.1126/science.1232458.
   PubMed Web of Science ®Google Scholar
• Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 339(6121):826–830. 10.1126/science.1229963.
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. 2016. Discovery of double-stranded genomic DNA in circulating exosomes. Cold Spring Harbor Symposia on Quantitative Biology. 81:275–280. 10.1101/sqb.2016.81.030932.
   PubMedGoogle Scholar
• Gonda A, Kabagwira J, Senthil GN, Wall NR. 2019. Internalization of exosomes through receptor-mediated endocytosis. Mol Cancer Res. 17(2):337–347. 10.1158/1541-7786.MCR-18-0891.
   PubMed Web of Science ®Google Scholar
• Kostyuk SV, Porokhovnik LN, Ershova ES, Malinovskaya EM, Konkova MS, Kameneva LV, Dolgikh OA, Veiko VP, Pisarev VM, Martynov AV, et al. Changes of KEAP1/NRF2 and IKB/NF-κB expression levels induced by cell-free DNA in different cell types. Oxid Med Cell Longev. 2018;1052413. doi:10.1155/2018/1052413.
   PubMed Web of Science ®Google Scholar
• Kostyuk SV, Konkova MS, Ershova ES, Alekseeva AJ, Smirnova TD, Stukalov SV, Kozhina EA, Shilova NV, Zolotukhina TV, Markova ZG, et al. 2013. An exposure to the oxidized DNA enhances both instability of genome and survival in cancer cells. PLoS One. 8(10):e77469. DOI:10.1371/journal.pone.0077469
   PubMed Web of Science ®Google Scholar
• Kostyuk SV, Alekseeva AY, Kon’kova MS, Glebova KV, Smirnova TD, Kameneva LV, Izhevskaya VL, Veiko NN. 2014. Oxidized extracellular DNA suppresses nitric oxide production by endothelial NO synthase (eNOS) in human endothelial cells (HUVEC). Bull Exp Biol Med. 157(2):202–206. 10.1007/s10517-014-2525-x.
   PubMed Web of Science ®Google Scholar
• Loseva P, Kostyuk S, Malinovskaya E, Clement N, Dechesne CA, Dani C, Smirnova T, Glebova K, Baidakova G, Baranova A, et al. 2012. Extracellular DNA oxidation stimulates activation of NRF2 and reduces the production of ROS in human mesenchymal stem cells. Expert Opin Biol Ther. 12(1):S85–S97. DOI:10.1517/14712598.2012.688948
   PubMedGoogle Scholar
• Konkova MS, Kaliyanov AA, Sergeeva VA, Abramova MS, Kostyuk SV. 2019. Oxidized cell-free DNA is a factor of stress signaling in radiation-induced bystander effects in different types of human cells. International Journal of Genomics. 2019:9467029. 10.1155/2019/9467029.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 2009. 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health, Part C. 27(2):120–139. 10.1080/10590500902885684.
   Web of Science ®Google Scholar
• Roszkowski K, Jozwicki W, Blaszczyk P, Mucha-Malecka A, Siomek A. 2011. Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer. Med Sci Monit. 17(6):CR329–CR333. 10.12659/msm.881805.
   PubMed Web of Science ®Google Scholar
• Sergeeva VA, Ershova ES, Veiko NN, Malinovskaya EM, Kalyanov AA, Kameneva LV, Stukalov SV, Dolgikh OA, Konkova MS, Ermakov AV, et al. 2017. Low-dose ionizing radiation affects mesenchymal stem cells via extracellular oxidized cell-free DNA: a possible mediator of bystander effect and adaptive response. Oxid Med Cell Longev. 2017:9515809. 10.1155/2017/9515809.
   PubMed Web of Science ®Google Scholar
• Ermakov AV, Konkova MS, Kostyuk SV, Izevskaya VL, Baranova A, Veiko NN. 2013. Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev. 2013:649747. 10.1155/2013/649747.
   PubMed Web of Science ®Google Scholar
• Glebova K, Veiko N, Kostyuk S, Izhevskaya V, Baranova A. 2015. Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy. Cancer Lett. 356(1):22–33. 10.1016/j.canlet.2013.09.005.
   PubMed Web of Science ®Google Scholar
• Guiducci C, Coffman RL, Barrat FJ. 2009. Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J Intern Med. 265(1):43–57. 10.1111/j.1365-2796.2008.02050.x.
   PubMed Web of Science ®Google Scholar
• Nathan C. 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 6(3):173–182. 10.1038/nri1785.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V, Zychlinsky A. 2009. NETs: a new strategy for using old weapons. Trends Immunol. 30(11):513–521. doi:10.1016/j.it.2009.07.011.
   PubMed Web of Science ®Google Scholar
• Kaplan MJ, Radic M. 2012. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. 189(6):2689–2695. 10.4049/jimmunol.1201719.
   PubMed Web of Science ®Google Scholar
• Liaw PC, Ito T, Iba T, Thachil J, Zeerleder ZS. 2016. DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev. 30(4):257–261. 10.1016/j.blre.2015.12.004.
   PubMed Web of Science ®Google Scholar
• Yousefi S, Simon D, Stojkov D, Karsonova A, Karaulov A, Simon H-U In vivo evidence for extracellular DNA trap formation. Cell Death Dis. 2020;11(4):300. Published 2020 Apr 30. doi:10.1038/s41419-020-2497-x.
   PubMed Web of Science ®Google Scholar
• Daniel C, Leppkes M, Muñoz LE, Schley G, Schett G, Extracellular HM. 2019. DNA traps in inflammation, injury and healing. Nat Rev Nephrol. 15(9):559–575. 10.1038/s41581-019-0163-2.
   PubMed Web of Science ®Google Scholar
• Lou H, Pickering MC. 2018. Extracellular DNA and autoimmune diseases. Cell Mol Immunol. 15(8):746–755. 10.1038/cmi.2017.136.
   PubMed Web of Science ®Google Scholar
• Tadie J-M, Bae H-B, Jiang S, Park DW, Bell CP, Yang H, Pittet J-F, Tracey K, Thannickal VJ, Abraham E, et al. 2013. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol. 304(5):L342–9. DOI:10.1152/ajplung.00151.2012
   PubMed Web of Science ®Google Scholar
• Neeli I, Dwivedi N, Khan S, Radic M. 2009. Regulation of extracellular chromatin release from neutrophils. J Innate Immun. 1(3):194–201. 10.1159/000206974.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, et al. 2009. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 184(2):205–213. DOI:10.1083/jcb.200806072
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Zychlinsky A. 2012. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol. 198(5):773–783. 10.1083/jcb.201203170.
   PubMed Web of Science ®Google Scholar
• Miller BF, Abrams R, Dorfman A, Klein M. 1942. Antibacterial properties of protamine and histone. Science. 96(2497):428–430. 10.1126/science.96.2497.428.
   PubMedGoogle Scholar
• Hirsch JG. 1958. Bactericidal action of histone. J Exp Med. 108(6):925–944. 10.1084/jem.108.6.925.
   PubMed Web of Science ®Google Scholar
• Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A, Levitz SM. 2009. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5(10):e1000639. 10.1371/journal.ppat.1000639.
   PubMed Web of Science ®Google Scholar
• Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT, Hartl D. 2012. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One. 7(2):e32366. 10.1371/journal.pone.0032366.
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Koyama T, Conlon JM, Yamakura F, Iwamuro S. 2008. Antimicrobial action of histone H2B in Escherichia coli: evidence for membrane translocation and DNA-binding of a histone H2B fragment after proteolytic cleavage by outer membrane proteinase T. Biochimie. 90(11–12):1693–1702. 10.1016/j.biochi.2008.07.003.
   PubMed Web of Science ®Google Scholar
• Lemaire S, Trinh -T-T, Le H-T, Tang S-C, Hincke M, Wellman-Labadie O, Ziai S. 2008. Antimicrobial effects of H4-(86-100), histogranin and related compounds - possible involvement of DNA gyrase. Febs J. 275(21):5286–5297. 10.1111/j.1742-4658.2008.06659.x.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ. 2010. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 584(14):3193–3197. 10.1016/j.febslet.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. 2009. Extracellular histones are major mediators of death in sepsis. Nat Med. 15(11):1318–1321. 10.1038/nm.2053.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. 2012. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol. 144(1):32–40. 10.1016/j.clim.2012.04.006.
   PubMed Web of Science ®Google Scholar
• Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y-H, Homey B, Cao W, Wang Y-H, Su B, Nestle FO, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 449(7162):564–569. DOI:10.1038/nature06116
   PubMed Web of Science ®Google Scholar
• Poli C, Augusto JF, Dauvé J, Adam C, Preisser L, Larochette V, Pignon P, Savina A, Blanchard S, Subra JF, et al. 2017. IL-26 confers proinflammatory properties to extracellular DNA. J Immunol. 198(9):3650–3661. DOI:10.4049/jimmunol.1600594
   PubMed Web of Science ®Google Scholar
• Hawes MC, Curlango-Rivera G, Wen F, White GJ, Vanetten HD, Xiong XZ. 2011. Extracellular DNA: the tip of root defenses?. Plant Sci. 180(6):741–745. 10.1016/j.plantsci.2011.02.007.
   PubMed Web of Science ®Google Scholar
• Wen F, White GJ, VanEtten HD, Xiong Z, Hawes MC. 2009. Extracellular DNA is required for root tip resistance to fungal infection. Plant Physiol. 151(2):820–829. 10.1104/pp.109.142067.
   PubMed Web of Science ®Google Scholar
• Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Küttner V, et al. 2018. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 361(eaao4227):1–13. DOI:10.1126/science.aao4227
   Google Scholar
• Aguirre-Ghiso JA. 2018. How dormant cancer persists and reawakens. Science. 361(6409):1315. 10.1126/science.aav0191.
   Web of Science ®Google Scholar
• Zeerleder S, Zwart B, Te Velthuis H, Stephan F, Manoe R, Rensink I, Aarden LA. 2008. Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP). Faseb J. 22(12):4077–4084. 10.1096/fj.08-110429.
   PubMed Web of Science ®Google Scholar
• Stephan F, Hazelzet JA, Bulder I, Boermeester MA, Van Till JW, Van Der Poll T, Wuillemin WA, Aarden LA, Zeerleder S. 2011. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care. 15(2):R110. 10.1186/cc10131.
   PubMed Web of Science ®Google Scholar
• Stephan F, Marsman G, Bakker LM, Bulder I, Stavenuiter F, Aarden LA, Zeerleder S. 2014. Cooperation of factor VII-activating protease and serum DNase I in the release of nucleosomes from necrotic cells. Arthritis Rheumatol. 66(3):686–693. 10.1002/art.38265.
   PubMed Web of Science ®Google Scholar
• Swystun LL, Mukherjee S, Liaw PC. 2011. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 9(11):2313–2321. 10.1111/j.1538-7836.2011.04465.x.
   PubMed Web of Science ®Google Scholar
• Massberg S, Grahl L, Von Bruehl M-L, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, et al. 2010. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 16(8):887–896. DOI:10.1038/nm.2184
   PubMed Web of Science ®Google Scholar
• Oehmcke S, Mörgelin M, Herwald H. 2009. Activation of the human contact system on neutrophil extracellular traps. J Innate Immun. 1(3):225–230. 10.1159/000203700.
   PubMed Web of Science ®Google Scholar
• Gansler J, Jaax M, Leiting S, Appel B, Greinacher A, Fischer S, Preissner KT. 2012. Structural requirements for the procoagulant activity of nucleic acids. PLoS ONE. 7(11):e50399(1–10). 10.1371/journal.pone.0050399.
   PubMed Web of Science ®Google Scholar
• Ward CM, Tetaz TJ, Andrews RK, Berndt MC. 1997. Binding of the von Willebrand factor A1 domain to histone. Thromb Res. 86(6):469–477. 10.1016/s0049-3848(97)00096-0.
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Brill A, Wagner DD. 2012. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 32(8):1777–1783. 10.1161/ATVBAHA.111.242859.
   PubMed Web of Science ®Google Scholar
• Chaaban H, Keshari RS, Silasi-Mansat R, Popescu NI, Mehta-D’Souza P, Lim YP, Lupu F. 2015. Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury. Blood. 125(14):2286–2296. 10.1182/blood-2014-06-582759.
   PubMed Web of Science ®Google Scholar
• Keeling PJ, Palmer JD. 2008. Horizontal gene transfer in eukaryotic evolution. Nat Rev Genet. 9(8):605–618. 10.1038/nrg2386.
   PubMed Web of Science ®Google Scholar
• Pelc SR. 1968. Turnover of DNA and function. Nature. 219(5150):162–163. 10.1038/219162a0.
   PubMed Web of Science ®Google Scholar
• Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR. 1972. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A. 69(7):1685–1689. 10.1073/pnas.69.7.1685.
   PubMed Web of Science ®Google Scholar
• Anker P, Stroun M, Maurice PA Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res. 1975;35(9):2375–2382. Published September 1975.
   PubMed Web of Science ®Google Scholar
• Bendich A, Wilczok T, Circulating BE. 1965. DNA as a possible factor in oncogenesis. Science. 148(3668):374–376. 10.1126/science.148.3668.374.
   PubMed Web of Science ®Google Scholar
• García-Olmo DC, Domínguez C, García-Arranz M, Anker P, Stroun M, García-Verdugo JM, García-Olmo D. 2010. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res. 70(2):560–567. 10.1158/0008-5472.CAN-09-3513.
   PubMed Web of Science ®Google Scholar
• Jaiswal R, Sedger LM Intercellular vesicular transfer by exosomes, microparticles and oncosomes – implications for cancer biology and treatments. Front Oncol. 2019;9:125. Published 2019 Mar 6. doi:10.3389/fonc.2019.00125.
   PubMed Web of Science ®Google Scholar
• Minciacchi VR, Freeman MR, Di Vizio D. 2015. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 40:41–51. 10.1016/j.semcdb.2015.02.010.
   PubMed Web of Science ®Google Scholar
• Trejo-Becerril C, Pérez-Cárdenas E, Dueñas-González A. 2014. In vivo rat model to study horizontal tumor progression. Methods Mol Biol. 1165:175–185. 10.1007/978-1-4939-0856-1_12.
   PubMedGoogle Scholar
• Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velázquez LA, Hidalgo-Miranda A, Pérez-Montiel D, Chávez-Blanco A, Cruz-Velázquez J, et al. 2012. Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One. 7(12):e52754. DOI:10.1371/journal.pone.0052754
   PubMed Web of Science ®Google Scholar
• Chan WF, Gurnot C, Montine TJ, Sonnen JA, Guthrie KA, Nelson JL. 2012. Male microchimerism in the human female brain. PLoS One. 7(9):e45592. 10.1371/journal.pone.0045592.
   PubMed Web of Science ®Google Scholar
• Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A, Prasannan P, Singh A, Iyer A, et al. 2015. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 40(1):91–111. DOI:10.1007/s12038-015-9508-6
   PubMed Web of Science ®Google Scholar
• Beljanski M, Bourgarel P, Beljanski M. 1981. Correlation between in vitro DNA synthesis, DNA strand separation and in vivo multiplication of cancer cells. Exp Cell Biol. 49(4):220–231. 10.1159/000163825.
   PubMedGoogle Scholar
• Xing R, Zhou Y, Yu J, Yu Y, Nie Y, Luo W, Yang C, Xiong T, Wu WKK, Li Z, et al. 2019. Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer. Nat Commun. 10(1):2037. DOI:10.1038/s41467-019-09644-6x
   PubMedGoogle Scholar
• Gravina S, Sedivy JM, Vijg J. 2016. The dark side of circulating nucleic acids. Aging Cell. 15(3):398–399. 10.1111/acel.12454.
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Storici F. 2012. A mechanism of gene amplification driven by small DNA fragments. PLoS Genet. 8(12):e1003119. 10.1371/journal.pgen.1003119.
   PubMed Web of Science ®Google Scholar
• Schaack S, Gilbert C, Promiscuous FC. 2010. DNA: horizontal transfer of transposable elements and why it matters for eukaryotic evolution. Trends Ecol Evol. 25(9):537–546. 10.1016/j.tree.2010.06.001.
   PubMed Web of Science ®Google Scholar
• Volik S, Alcaide M, Morin RD, Cell-free CC. 2016. DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res. 14(10):898–908. 10.1158/1541-7786.MCR-16-0044.
   PubMed Web of Science ®Google Scholar
• Tuomela J, Sandholm J, Kaakinen M, Patel A, Kauppila JH, Ilvesaro J, Chen D, Harris KW, Graves D, Selander KS. 2013. DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat. 142(3):477–487. 10.1007/s10549-013-2762-0.
   PubMed Web of Science ®Google Scholar
• Garcia-Arranz M, Garcia-Olmo D, Vega-Clemente L, Stroun M, Preliminary A. 2017. Study of the action of virtosomes from non-dividing cells on tumour cell replication in vitro and in vivo. Anticancer Agents Med Chem. 17(10):1401–1410. 10.2174/1871520617666170213110536.
   PubMed Web of Science ®Google Scholar
• García-Olmo D, Garcia-Arranz M, Clemente LV, GahanPB SM 2015. Method for blocking tumour growth. European Patent 2015. Application number 13169783.1 (EP 2 808 027 A1).
   Google Scholar
• Fiala C, Diamandis E. 2018. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
. BMC Med. 16(166):1–10. 10.1186/s12916-018-1157-9.
   Google Scholar
• Heitzer E, Haque IS, Roberts CE, Speicher MR. 2019. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nature Rev Genetics. 20:71–88. 10.1038/s4576-018-0071-5.
   PubMed Web of Science ®Google Scholar
• Boto L. 2010. Horizontal gene transfer in evolution: facts and challenges. Proc Biol Sci. 277(1683):819–827. 10.1098/rspb.2009.1679.
   PubMed Web of Science ®Google Scholar
• Linardou H, Decnarain MP, Epenetos AA. 1995. Recombinant deoxyribonuclease I (DNAse I) and chimeras in cancer therapy. Eur J Cancer. 31(6):s30. 10.1016/0959—8049(95)95383-H.
   Google Scholar
• Hawes MC, Wen F, Extracellular EE. 2015. DNA: a bridge to cancer. Cancer Res. 75(20):4260–4264. 10.1158/0008-5472.CAN-15-1546.
   PubMed Web of Science ®Google Scholar
• Serpas L, Chan RWY, Jiang P, Ni M, Sun K, Rashidfarrokhi A, Soni C, Sisirak V, Lee WS, Cheng SH, et al. 2019. Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA. Proc Natl Acad Sci U S A. 116(2):641–649. DOI:10.1073/pnas.1815031116
   PubMed Web of Science ®Google Scholar
• Alcázar-Leyva S, Cerón E, Masso F, Montaño LF, Gorocica P, Alvarado-Vásquez N. Incubation with DNase I inhibits tumor cell proliferation. Med Sci Monit. 2009;15(2):CR51–55.
   PubMed Web of Science ®Google Scholar
• Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2020;1–18. doi:10.1007/s12016-020-08804-7.
   Web of Science ®Google Scholar
• Smalheiser NE. 2019. Mining clinical case reports to identify new lines of investigation in Alzheimer´s disease: the curious case of DNAse I. J Alzheimers Dis Rep. 3(1):71–76. 10.3233/ADR-190100.
   PubMedGoogle Scholar
• Stefanius K, Servage K, De Souza Santos M, Gray HF, Toombs JE, Chimalapati S, Kim MS, Malladi VS, Brekken R, Orth K. 2019. Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation. Elife. 8:e40226. 10.7554/eLife.40226.
   PubMed Web of Science ®Google Scholar